window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Manufacturing & Supply Chain,Research & Development

    Saudi Arabia announces biotech deals and research partnerships worth SAR 5.5BN

    Saudi Arabia has announced more than SAR 5 billion in [...]

    September 18, 2026
  • Genomics and sequencing,Research & Development,Therapeutic Areas

    Nabsys EGM detects genomic abnormalities in five-sample leukemia study

    Nabsys’ Electronic Genome Mapping technology detected clinically relevant genomic abnormalities [...]

    September 17, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Genomics and sequencing

    MaxCyte launches off-target assays for adenine and cytosine base editors

    MaxCyte has launched two sequencing-based assays to identify potential off-target [...]

    August 19, 2026
  • Advanced Therapies,Central Nervous System,Genomics and sequencing,Research & Development

    Researchers develop electromagnetic gene switch for remote control of gene expression

    Researchers at Dongguk University in South Korea have developed an [...]

    August 17, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Tagomics launches cfDNA platform for multi-organ drug safety monitoring

    Tagomics has launched a cell-free DNA platform designed to monitor [...]

    August 17, 2026
  • Advanced Therapies,Clinical & Regulatory,Genomics and sequencing,Research & Development,Therapeutic Areas

    Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness

    Skylark Bio has dosed the first patient in a Phase [...]

    August 13, 2026
  • Biotech & Pharma Business,Digital & Data,Genomics and sequencing,Research & Development,Therapeutic Areas

    Bios Life launches with $25M funding and Tempus cancer AI partnership

    Bios Life has emerged from stealth with $25M in seed [...]

    August 12, 2026
  • Central Nervous System,Genomics and sequencing,Research & Development,Therapeutic Areas

    Alamar expands Alzheimer’s proteomics partnership with 86,000 more samples

    Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

    August 12, 2026
  • Advanced Therapies,Drug Discovery & Development,Genomics and sequencing

    Broken String Biosciences launches BaseMap ABE for genome-wide off-target analysis

    Broken String Biosciences has launched BaseMap ABE, a platform designed [...]

    August 10, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    NEB launches cell-free RNA extraction kit for liquid biopsy research Slug: neb-c

    New England Biolabs has launched a magnetic bead-based extraction kit [...]

    August 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Sapience Therapeutics gets FDA clearance for ST316 FAP study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • EURneffy recommended for emergency anaphylaxis treatment in NHS Wales
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Lifebit awarded three-year NIHR BioResource research environment contract
    Categories: Biotech & Pharma Business, Digital & Data, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top